Literature DB >> 8666101

Home treatment for chronic respiratory failure in children: a prospective study.

B Fauroux1, A Sardet, D Foret.   

Abstract

Home treatment for children with chronic respiratory failure (CRF) is increasing. However, the causes of CRF in children and the details of their home treatment are not well-known. The aim of this study was to describe the causes of CRF in the paediatric population and the treatments that the patients received at home. We surveyed all children (aged < or = 18 yrs) entering the Association Nationale pour le Traitement à Domicile de l'Insuffisance Respiratoire chronique (ANTADIR) for home treatment of CRF between March 1992 and March 1993. Two hundred and eighty seven children (178 boys, 62%) started home treatment for CRF during the year. One hundred and eleven patients had obstructive respiratory disease: cystic fibrosis (CF) (n = 24); bronchopulmonary dysplasia (BPD) (n = 79); other obstructive respiratory disease (n = 8). One hundred and seventy six patients had restrictive lung disease: neuromuscular disease (n = 87); kyphoscoliosis (n = 21); pulmonary fibrosis (n = 6); cardiac disease (n = 14); stomatological disease (n = 10); other restrictive respiratory disease (n = 9); and 29 miscellaneous causes. One hundred and thirteen patients received oxygen therapy, with a mean daily use of 17.7 h (20 h.day-1 for BPD patients and 12.3 h.day-1 for CF patients). Oxygen was delivered by a concentrator in 88% of cases. One hundred and fifty eight children received mechanical ventilation (MV). Five children received nasal continuous positive airway pressure ventilation for sleep apnoea, four had pneumatic belt ventilation, and 12 had a tracheostomy without MV. Treatment was stopped in 21 children, because of death in nine and improvement in the other 12. Home treatment for children with CRF is well developed in France via the ANTADIR network. Causes of CRF in children are heterogeneous, with a relatively good prognosis.

Entities:  

Mesh:

Year:  1995        PMID: 8666101     DOI: 10.1183/09031936.95.08122062

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  How long does it take to initiate a child on long-term invasive ventilation? Results from a Canadian pediatric home ventilation program.

Authors:  Reshma Amin; Aarti Sayal; Faiza Syed; Cathy Daniels; Andrea Hoffman; Theo J Moraes; Peter Cox
Journal:  Can Respir J       Date:  2015 Mar-Apr       Impact factor: 2.409

Review 2.  Ventilatory support at home for children: A joint position paper from the Thoracic Society of Australia and New Zealand/Australasian Sleep Association.

Authors:  Jasneek Chawla; Elizabeth A Edwards; Amanda L Griffiths; Gillian M Nixon; Sadasivam Suresh; Jacob Twiss; Moya Vandeleur; Karen A Waters; Andrew C Wilson; Susan Wilson; Andrew Tai
Journal:  Respirology       Date:  2021-08-13       Impact factor: 6.175

3.  Sending children home on tracheostomy dependent ventilation: pitfalls and outcomes.

Authors:  E A Edwards; M O'Toole; C Wallis
Journal:  Arch Dis Child       Date:  2004-03       Impact factor: 3.791

4.  Liberation and mortality outcomes in pediatric long-term ventilation: A qualitative systematic review.

Authors:  Candice M Foy; Monica L Koncicki; Jeffrey D Edwards
Journal:  Pediatr Pulmonol       Date:  2020-08-12

5.  Parental Perceptions of Quality of Life in Children on Long-Term Ventilation at Home as Compared to Enterostomy Tubes.

Authors:  Brahim Redouane; Eyal Cohen; Derek Stephens; Krista Keilty; Marialena Mouzaki; Unni Narayanan; Theo Moraes; Reshma Amin
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

Review 6.  Respiratory Care Considerations for Children with Medical Complexity.

Authors:  Jackie Chiang; Reshma Amin
Journal:  Children (Basel)       Date:  2017-05-19

7.  Pediatric Home Mechanical Ventilation in Korea: the Present Situation and Future Strategy.

Authors:  Mireu Park; Haerin Jang; In Suk Sol; Soo Yeon Kim; Young Suh Kim; Yoon Hee Kim; Myung Hyun Sohn; Kyung Won Kim
Journal:  J Korean Med Sci       Date:  2019-11-04       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.